Satellos Bioscience Inc. (TSE:MSCL) has released an update.
Satellos Bioscience Inc., a biotech firm focusing on novel treatments for muscle diseases, will be presenting at the Bloom Burton & Co. Healthcare Investor Conference on April 16, 2024, in Toronto. The CEO, Frank Gleeson, will deliver a corporate presentation and engage in one-on-one meetings. The event will be webcast live, with a replay available on the company’s website.
For further insights into TSE:MSCL stock, check out TipRanks’ Stock Analysis page.
